Ito et al., 2012 - Google Patents
Involvement of insulin-like growth factor 1 receptor signaling in the amyloid-β peptide oligomers-induced p75 neurotrophin receptor protein expression in mouse …Ito et al., 2012
View PDF- Document ID
- 7530222444304181749
- Author
- Ito S
- Ménard M
- Atkinson T
- Gaudet C
- Brown L
- Whitfield J
- Chakravarthy B
- Publication year
- Publication venue
- Journal of Alzheimer's Disease
External Links
Snippet
The p75 neurotrophin receptor (p75NTR) has been thought to play a critical role in amyloid- β peptide (Aβ)-mediated neurodegeneration and Aβ metabolism in Alzheimer's disease (AD) brains. Our previous report showed that membrane-associated p75NTR protein …
- 102000007339 Nerve Growth Factor Receptors 0 title abstract description 165
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ito et al. | Involvement of insulin-like growth factor 1 receptor signaling in the amyloid-β peptide oligomers-induced p75 neurotrophin receptor protein expression in mouse hippocampus | |
| Muhammad et al. | Melatonin rescue oxidative stress-mediated neuroinflammation/neurodegeneration and memory impairment in scopolamine-induced amnesia mice model | |
| Pei et al. | Astrocyte-derived exosomes suppress autophagy and ameliorate neuronal damage in experimental ischemic stroke | |
| Liu et al. | The role of NMDA receptors in Alzheimer’s disease | |
| Gulisano et al. | Neuromodulatory action of picomolar extracellular Aβ42 oligomers on presynaptic and postsynaptic mechanisms underlying synaptic function and memory | |
| Huang et al. | Astrocytic glutamatergic transporters are involved in Aβ-induced synaptic dysfunction | |
| Tan et al. | Aminoglycoside-induced degeneration of adult spiral ganglion neurons involves differential modulation of tyrosine kinase B and p75 neurotrophin receptor signaling | |
| Sotthibundhu et al. | Aβ1–42 stimulates adult SVZ neurogenesis through the p75 neurotrophin receptor | |
| Kuric et al. | Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke | |
| Lei et al. | L-3-n-butylphthalide regulates proliferation, migration, and differentiation of neural stem cell in vitro and promotes neurogenesis in APP/PS1 mouse model by regulating BDNF/TrkB/CREB/Akt pathway | |
| Mockett et al. | Glutamate receptor trafficking and protein synthesis mediate the facilitation of LTP by secreted amyloid precursor protein-alpha | |
| Kataria et al. | Small molecule agonists of cell adhesion molecule L1 mimic L1 functions in vivo | |
| Qin et al. | Astrocytic p75NTR expression provoked by ischemic stroke exacerbates the blood–brain barrier disruption | |
| Li et al. | Electroacupuncture treatment improves motor function and neurological outcomes after cerebral ischemia/reperfusion injury | |
| Durand et al. | Amyloid-beta neurotoxicity and clearance are both regulated by glial group II metabotropic glutamate receptors | |
| Sun et al. | The proform of glia cell line-derived neurotrophic factor: a potentially biologically active protein | |
| Christie et al. | Intraganglionic interactions between satellite cells and adult sensory neurons | |
| Gao et al. | Induced neural stem cells modulate microglia activation states via CXCL12/CXCR4 signaling | |
| Göttle et al. | An unmet clinical need: roads to remyelination in MS | |
| Haldipur et al. | HIP/PAP prevents excitotoxic neuronal death and promotes plasticity | |
| Bachis et al. | The neurotrophin receptor p75 mediates gp120-induced loss of synaptic spines in aging mice | |
| Baya Mdzomba et al. | Nogo-A-targeting antibody promotes visual recovery and inhibits neuroinflammation after retinal injury | |
| Nelson et al. | Noradrenergic sympathetic sprouting and cholinergic reinnervation maintains non-amyloidogenic processing of AβPP | |
| Butowt et al. | Anterograde axonal transport of BDNF and NT-3 by retinal ganglion cells: roles of neurotrophin receptors | |
| Ahmed et al. | Epidermal growth factor receptor inhibitors promote CNS axon growth through off-target effects on glia |